Celcuity Stock Skyrockets 40% to Record High on ‘Practice-Changing’ Cancer Trial Results
Stock Soars on Positive Trial News Celcuity’s stock price skyrocketed on October 20, 2025 after the Minneapolis-based biotech reported game-changing clinical trial results. Shares jumped from around $52 to as high as